The GORE TAG Thoracic Endoprosthesis (TAG) device (W. L. Gore & Associates, Flagstaff, Ariz) and the GORE Conformable TAG Thoracic Endoprosthesis (CTAG) are commonly implanted and effective stent grafts for use during thoracic endovascular aortic repair. Precise placement of the endograft is paramount during thoracic endovascular aortic repair, but like all thoracic stent grafts, maldeployment with inaccurate landing has been reported. The partial distal deployment technique describes an alteration of the TAG and CTAG deployment mechanism to allow isolated deployment of the distal half of the graft, which provides stability during deployment. The graft can be safely repositioned after partial distal deployment, thus allowing precise positioning in the proximal landing zone. Similarly, this technique can be used for precision in the distal landing zone, making the TAG and CTAG devices the only thoracic endografts currently available in the United States with a distal-first deployment option. A discussion of the usefulness of this technique and potential pitfalls is included. (J Vasc Surg 2017;66:661-5.) 
deployment, the stent graft is held in a compressed state by a sleeve of expanded polytetrafluoroethylene (ePTFE). A pull-cord delivery system unlaces the ePTFE sleeve to deploy the stent graft. By design, the endograft opens from the center outward in a proximal and distal direction simultaneously until fully deployed.
Despite the ease of positioning and deployment of the TAG devices, anecdotal experiences describe incidences of endograft movement during deployment, leading to inaccurate placement. 5, 6 Often, avoiding imprecision in placement is a matter of understanding the nuances of the individual endograft delivery and deployment system. 7, 8 For example, the TAG and CTAG perform optimally when forward tension is imparted on the aortic wire, thus driving the stent graft along the outer aortic curvature for stability during deployment. However, in cases where precise landing is paramount, a slight alteration of the TAG/CTAG deployment mechanism is presented here, offering an alternate method for improved endograft placement: the partial distal deployment technique.
TECHNIQUE
Informed consent was obtained from the patient, specifically discussing the use of this technique for TEVAR.
Once the selected TAG/CTAG graft is prepared and flushed on the sterile field, the deployment knob is loosened and retracted approximately 1 cm. Doing so exposes the deployment line system, which consists of two strings tethered to the sewn deployment sleeve. One string is grasped with a hemostat (Fig 1, A) and divided from the deployment knob while the other string remains fully attached to the deployment knob, thus allowing each line to be manipulated independently (Fig 1, B) . Looking now at the middle third of the exposed sleeve constraining the stent graft, the same two strings are identified as loops of redundant cord arising from the seam of the ePTFE sleeve (Fig 1, C) . Intuitively, the proximal loop releases the proximal half of the endograft when pulled and the distal loop releases the distal half.
Once these loops are seen, the stylet that is included with the device packaging is removed from the end hole of the delivery catheter and placed through each loop to prevent premature deployment of the endograft. A slight retraction on the deployment knob will cinch either the proximal or distal loop, thus defining which string is attached to the deployment knob and the hemostat, respectively (Fig 1, D) . Once this step is completed, the stylet can be removed from the deployment sleeve loops and the device inserted over the aortic wire in standard fashion.
Once positioned close to the desired deployment location, the distal constraining string is individually pulled with the deployment knob or the hemostat until the distal half of the endograft is deployed (Fig 2, A) . The proximal half of the endograft will remain constrained and undeployed. Importantly, stent graft repositioning in a proximal direction may be performed at this point if desired (Fig 2, B) , thus allowing for a precise proximal landing location. Once the intended deployment position is realized, the proximal deployment line string is retracted to deploy the remainder of the endograft (Fig 2, C) . The delivery catheter is removed, and the procedure is completed with standard techniques.
DISCUSSION
Endovascular repair of the thoracic aorta requires full confidence in the equipment and techniques used to complete the procedure. Perhaps one of the most important features of a thoracic endograft is the ability to precisely deploy and land the graft. This is especially true when the proximal or distal landing zone is of marginally adequate length. Equally relevant is a planned zone 1 or zone 2 placement, wherein endograft movement during deployment can potentially lead to atheroembolization or unintended coverage of the aortic arch branches, or both, with dire consequences.
Five thoracic stent grafts are currently approved for use in the United States, and each device has a slightly different deployment mechanism. Maldeployment and inaccurate placement have been reported with each of these devices. 9, 10 Notably, the endograft in each of these devices is deployed in a proximal-to-distal orientation, and thus, the distal endograft margin is a common site of inaccurate placement. The TAG/CTAG device is unique in both its pull-cord mechanism and center-outward graft deployment. The design is simple, but the ultimate stent graft position is affected by multiple factors interacting during deployment, all of which require critical attention to achieve optimal placement. One of the most important of these is wire tension. A firm proximal advancement pressure on the stiff aortic wire pushes against the aortic valve and forces the wire and endograft along the outer curvature of the aorta. Because of the center-outward deployment, the graft first opposes the aortic wall at the center of the graft, which becomes the stabilization point for the rest of the deployment. In a dissection or transection, this mode of deployment may not pose an issue because the graft generally has appropriate wall apposition throughout the expansion process. In an aneurysm, however, the middle segment of the graft may not contact Fig 1. A, The deployment knob is retracted w1 cm to expose the two deployment strings attached to the endograft deployment sleeve. B, One string is grasped with a hemostat and divided, releasing it from the deployment knob; the other string remains undisturbed. Each string can now be manipulated independently. C, The proximal and distal deployment line strings are exposed on the deployment sleeve after retraction of the deployment knob w1 cm. D, The stylet included in the device packaging is threaded through both loops to prevent premature deployment. Further retraction of the deployment knob results in a tightening of one of the loops on the endograft (in this case the proximal deployment string). The proximal loop controls release of the proximal half of the stent graft and vice versa. Fig 2. A, Pulling the distal deployment line string deploys only the distal half of the GORE TAG Thoracic Endoprosthesis (TAG) device (W. L. Gore & Associates, Flagstaff, Ariz) and the GORE Conformable TAG Thoracic Endoprosthesis (CTAG), while the proximal half of the endograft remains constrained. The endograft is positioned well below the intended proximal landing zone, which is just distal to the left subclavian artery in this chronic aortic dissection. B, The endograft is advanced to the desired landing zone after partial distal deployment; pulling the remaining deployment line string will deploy the proximal half of the endograft. C, The endograft is fully deployed at the desired proximal landing zone with exclusion of the false lumen of this chronic aortic dissection.
the aortic wall at all, and thus, the graft has little stabilization until it touches the aorta proximal or distal to the aneurysm. This is the situation in which the potential for graft movement during deployment is the greatest.
Further, wire tension plays a critical role: too much forward tension and the graft may "jump" forward during deployment; too little wire tension and the graft will be delayed in contacting the aortic wall, thus allowing the force of the cardiac cycle to push the graft in a distal direction. Obtaining the optimal balance for a satisfactory deployment requires both experience and a close evaluation of the aortic anatomy.
The partial distal deployment technique for the TAG/ CTAG device is effective because it adds more stability to the stent graft during deployment. Once the distal deployment line is pulled independently and the distal half of the endograft is deployed, the graft becomes immediately secured to the aortic wall. With half of the stent graft contacting the aorta, it is essentially anchored in the distal segment, decreasing the opportunity for movement during deployment of the proximal half. As such, determining where the proximal edge of the stent graft will land is predictable. Conversely, there are cases of distal descending thoracic aortic aneurysm or aortic dissection whose procedural success depends entirely on the ability to precisely land the distal endograft at the proximal margin of the celiac or superior mesenteric artery. Inaccurate placement is not uncommon in these scenarios, often due to foreshortening of the graft into the aneurysm sac or a miscalculation of required graft length within existing aortic tortuosity. Use of the partial distal deployment technique in these circumstances would provide improved accuracy in the distal landing zone, allowing for a distal-to-proximal construct if additional pieces are required.
I have used the partial distal deployment technique in eight cases to date (dissection, n ¼ 4; aneurysm, n ¼ 3; transection, n ¼ 1). Except for the case described here, the decision to use this technique was made intraoperatively to address anticipated difficulties in accurate device placement. Five times the concern was the proximal landing zone (type III arch, n ¼ 2; zone 3 landing after carotid-subclavian bypass, n ¼ 3), and in the other four patients, the concern was the distal landing zone (landing at celiac, n ¼ 1; landing at superior mesenteric artery, n ¼ 3). The mean distance of proximal advancement after partial distal deployment was 2.4 6 1.6 cm. In all cases, the final position of the endograft was #2 mm of the desired location. There were no complications, and specifically, no neurologic or distal embolization events were observed. No additional proximal or distal extension pieces have been required secondary to inaccurate landing when using the partial distal deployment technique.
Initial concerns regarding the security of the proximal half of the stent graft after deployment of the distal portion have been unrealized. In my experience, the proximal half of the stent graft remains fully constrained until the proximal deployment line is pulled. Specifically, this remains true if proximal advancement is required to achieve precise positioning. To date, I have not observed spontaneous deployment or unanticipated release of the proximal deployment sleeve in a limited experience. The stent graft advances easily to the desired deployment position without substantial resistance, and there is no suggestion of consequential mural injury in the manipulated region distally. Additional trepidation surrounding loss of control of the cut deployment string has not been observed. In the circumstance where this would occur, the deployment strings can be exposed and resecured by unroofing the material on the catheter shaft adjacent to the hub (in concert with the device representative).
Several important limitations must be mentioned. Partial deployment of the proximal half of the stent graft first will create a "windsock," effectively occluding the descending thoracic aorta with the expected physiologic response. The distal graft is unlikely to spontaneously deploy in this situation, and similar to most other stent grafts, the potential for distal migration away from the desired landing position remains applicable. Adjustment of the mean arterial pressure or rapid ventricular pacing can minimize the consequence of the windsock effect; however, partial distal deployment may allow the operator to avoid mechanical or pharmacologic manipulation of cardiac output or systolic blood pressure as a means to aid in accurate landing. We routinely label the hemostat and deployment knob as "proximal" and "distal" to eliminate inadvertent partial proximal deployment.
Second, to maximize the efficacy of this technique, an appropriate length stent graft should be selected to allow the distal portion of the endograft to be apposed to the aortic wall after partial distal deployment. If the distal half of the stent graft is positioned within the aneurysm sac, the anchoring effect of the partial distal deployment will be lost, thus eliminating the primary benefit of this technique. In addition, patients with a significant amount of atherosclerotic plaque or mural thrombus (ie, shaggy aorta) in the descending thoracic segment should be approached with caution. Advancement of a partially deployed stent graft in this situation may result in distal embolization with significant clinical consequence. Similarly, once the distal segment is partially deployed, retraction of the device distally may be met with significant resistance or cause a snow-plow effect, resulting in significant injury to the aortic intima or distal embolization of mural thrombus. Avoidance of these potential pitfalls is recommended to optimize use of this technique.
Partial distal deployment of the GORE thoracic endografts is not necessary for all cases, but rather offers an alternative approach to overcome endograft limitations in challenging anatomy. With increased scrutiny of offlabel use of vascular devices, it may be advisable to involve an institutional review board or pursue investigational device exemption, or both, for more widespread use of this technique in the future.
CONCLUSIONS
The partial distal deployment technique for the GORE TAG and CTAG devices creates additional stabilization of the stent graft during deployment, offering accurate landing in most clinical scenarios. In addition, this technique distinguishes the TAG and CTAG devices as the only thoracic aortic stent grafts with the ability to deploy the distal portion of the stent graft first, uniquely aiding in precise distal positioning. More experience is needed; however, this technique stands to be an important tool to minimize deployment migration and inaccurate placement during TEVAR.
